218 related articles for article (PubMed ID: 35288215)
1. Heart-Type Fatty Acid Binding Protein, Cardiovascular Outcomes, and Death: Findings From the German CKD Cohort Study.
Schneider MP; Schmid M; Nadal J; Wanner C; Krane V; Floege J; Saritas T; Busch M; Sitter T; Friedrich N; Stockmann H; Meiselbach H; Nauck M; Kronenberg F; Eckardt KU;
Am J Kidney Dis; 2022 Oct; 80(4):483-494.e1. PubMed ID: 35288215
[TBL] [Abstract][Full Text] [Related]
2. Copeptin, Natriuretic Peptides, and Cardiovascular Outcomes in Patients With CKD: The German Chronic Kidney Disease (GCKD) Study.
Schneider MP; Schmid M; Nadal J; Krane V; Saritas T; Busch M; Schultheiss UT; Meiselbach H; Friedrich N; Nauck M; Floege J; Kronenberg F; Wanner C; Eckardt KU;
Kidney Med; 2023 Nov; 5(11):100725. PubMed ID: 37915964
[TBL] [Abstract][Full Text] [Related]
3. Predictors of high sensitivity cardiac troponin T in chronic kidney disease patients: a cross-sectional study in the chronic renal insufficiency cohort (CRIC).
Dubin RF; Li Y; He J; Jaar BG; Kallem R; Lash JP; Makos G; Rosas SE; Soliman EZ; Townsend RR; Yang W; Go AS; Keane M; Defilippi C; Mishra R; Wolf M; Shlipak MG;
BMC Nephrol; 2013 Oct; 14():229. PubMed ID: 24148285
[TBL] [Abstract][Full Text] [Related]
4. Association of mineral and bone biomarkers with adverse cardiovascular outcomes and mortality in the German Chronic Kidney Disease (GCKD) cohort.
Reimer KC; Nadal J; Meiselbach H; Schmid M; Schultheiss UT; Kotsis F; Stockmann H; Friedrich N; Nauck M; Krane V; Eckardt KU; Schneider MP; Kramann R; Floege J; Saritas T;
Bone Res; 2023 Oct; 11(1):52. PubMed ID: 37857629
[TBL] [Abstract][Full Text] [Related]
5. Heart-type fatty acid-binding protein is more sensitive than troponin T to detect the ongoing myocardial damage in chronic heart failure patients.
Niizeki T; Takeishi Y; Arimoto T; Takabatake N; Nozaki N; Hirono O; Watanabe T; Nitobe J; Harada M; Suzuki S; Koyama Y; Kitahara T; Sasaki T; Kubota I
J Card Fail; 2007 Mar; 13(2):120-7. PubMed ID: 17395052
[TBL] [Abstract][Full Text] [Related]
6. Impact of Chronic Kidney Disease on the Associations of Cardiovascular Biomarkers With Adverse Outcomes in Patients With Suspected or Known Coronary Artery Disease: The EXCEED-J Study.
Wada H; Shinozaki T; Suzuki M; Sakagami S; Ajiro Y; Funada J; Matsuda M; Shimizu M; Takenaka T; Morita Y; Yonezawa K; Matsubara H; Ono Y; Nakamura T; Fujimoto K; Ninomiya A; Kato T; Unoki T; Takagi D; Wada K; Wada M; Iguchi M; Yamakage H; Kusakabe T; Yasoda A; Shimatsu A; Kotani K; Satoh-Asahara N; Abe M; Akao M; Hasegawa K;
J Am Heart Assoc; 2022 Feb; 11(3):e023464. PubMed ID: 35048713
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the Association Between High-Sensitivity Troponin I and Adverse Cardiovascular Outcomes in Patients With Versus Without Chronic Kidney Disease.
Sandesara PB; O'Neal WT; Tahhan AS; Hayek SS; Lee SK; Khambhati J; Topel ML; Hammadah M; Alkhoder A; Ko YA; Gafeer MM; Beshiri A; Murtagh G; Kim JH; Wilson P; Shaw L; Epstein SE; Sperling LS; Quyyumi AA
Am J Cardiol; 2018 Jun; 121(12):1461-1466. PubMed ID: 29628129
[TBL] [Abstract][Full Text] [Related]
8. Elevated levels of both cardiomyocyte membrane and myofibril damage markers predict adverse outcomes in patients with chronic heart failure.
Setsuta K; Seino Y; Kitahara Y; Arau M; Ohbayashi T; Takano T; Mizuno K
Circ J; 2008 Apr; 72(4):569-74. PubMed ID: 18362427
[TBL] [Abstract][Full Text] [Related]
9. Association Between High-Sensitivity Cardiac Troponin T and Echocardiographic Parameters in Chronic Kidney Disease: Results From the KNOW-CKD Cohort Study.
Kang E; Ryu H; Kim J; Lee J; Lee KB; Chae DW; Sung SA; Kim SW; Ahn C; Oh KH
J Am Heart Assoc; 2019 Sep; 8(18):e013357. PubMed ID: 31514574
[TBL] [Abstract][Full Text] [Related]
10. Predictive Properties of Biomarkers GDF-15, NTproBNP, and hs-TnT for Morbidity and Mortality in Patients With Type 2 Diabetes With Nephropathy.
Bidadkosh A; Lambooy SPH; Heerspink HJ; Pena MJ; Henning RH; Buikema H; Deelman LE
Diabetes Care; 2017 Jun; 40(6):784-792. PubMed ID: 28341782
[TBL] [Abstract][Full Text] [Related]
11. Time-Updated Changes in Estimated GFR and Proteinuria and Major Adverse Cardiac Events: Findings from the Chronic Renal Insufficiency Cohort (CRIC) Study.
Cohen JB; Yang W; Li L; Zhang X; Zheng Z; Orlandi P; Bansal N; Deo R; Lash JP; Rahman M; He J; Shafi T; Chen J; Cohen DL; Matsushita K; Shlipak MG; Wolf M; Go AS; Feldman HI;
Am J Kidney Dis; 2022 Jan; 79(1):36-44.e1. PubMed ID: 34052355
[TBL] [Abstract][Full Text] [Related]
12. Different characteristics of cardiac biomarkers to decide and predict the culprit lesions in patients with suspicious acute coronary syndrome.
Kitamura M; Hata N; Takayama T; Hirayama A; Ogawa M; Yamashina A; Mera H; Yoshino H; Nakamura F; Seino Y
Heart Vessels; 2016 Jun; 31(6):907-17. PubMed ID: 26081026
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Value of High-Sensitivity Versus Conventional Cardiac Troponin T Assays Among Patients With Type 2 Diabetes Mellitus Undergoing Maintenance Hemodialysis.
Keller T; Wanner C; Krane V; Kraus D; Genser B; Scharnagl H; März W; Drechsler C
Am J Kidney Dis; 2018 Jun; 71(6):822-830. PubMed ID: 29310884
[TBL] [Abstract][Full Text] [Related]
14. Point-of-care heart-type fatty acid binding protein versus high-sensitivity troponin T testing in emergency patients at high risk for acute coronary syndrome.
Kellens S; Verbrugge FH; Vanmechelen M; Grieten L; Van Lierde J; Dens J; Vrolix M; Vandervoort P
Eur Heart J Acute Cardiovasc Care; 2016 Apr; 5(2):177-84. PubMed ID: 25666938
[TBL] [Abstract][Full Text] [Related]
15. Nonalbuminuric Diabetic Kidney Disease and Risk of All-Cause Mortality and Cardiovascular and Kidney Outcomes in Type 2 Diabetes: Findings From the Hong Kong Diabetes Biobank.
Jin Q; Luk AO; Lau ESH; Tam CHT; Ozaki R; Lim CKP; Wu H; Jiang G; Chow EYK; Ng JK; Kong APS; Fan B; Lee KF; Siu SC; Hui G; Tsang CC; Lau KP; Leung JY; Tsang MW; Kam G; Lau IT; Li JK; Yeung VT; Lau E; Lo S; Fung S; Cheng YL; Chow CC; Huang Y; Lan HY; Szeto CC; So WY; Chan JCN; Ma RCW;
Am J Kidney Dis; 2022 Aug; 80(2):196-206.e1. PubMed ID: 34999159
[TBL] [Abstract][Full Text] [Related]
16. High-sensitivity Troponin T Assay in Asymptomatic High Cardiovascular Risk Patients. The TUSARC Registry.
Álvarez I; Hernández L; García H; Villamandos V; López MG; Palazuelos Molinero J; Martín Raymondi D
Rev Esp Cardiol (Engl Ed); 2017 Apr; 70(4):261-266. PubMed ID: 28017545
[TBL] [Abstract][Full Text] [Related]
17. Estimated Glomerular Filtration Rate, Activation of Cardiac Biomarkers and Long-Term Cardiovascular Outcomes: A Population-Based Cohort.
Vinnakota S; Scott CG; Rodeheffer RJ; Chen HH
Mayo Clin Proc; 2019 Nov; 94(11):2189-2198. PubMed ID: 31668448
[TBL] [Abstract][Full Text] [Related]
18. Association between cardiac biomarkers and the development of ESRD in patients with type 2 diabetes mellitus, anemia, and CKD.
Desai AS; Toto R; Jarolim P; Uno H; Eckardt KU; Kewalramani R; Levey AS; Lewis EF; McMurray JJ; Parving HH; Solomon SD; Pfeffer MA
Am J Kidney Dis; 2011 Nov; 58(5):717-28. PubMed ID: 21820220
[TBL] [Abstract][Full Text] [Related]
19. Prognostic utility of heart-type fatty acid binding protein in patients with acute coronary syndromes.
O'Donoghue M; de Lemos JA; Morrow DA; Murphy SA; Buros JL; Cannon CP; Sabatine MS
Circulation; 2006 Aug; 114(6):550-7. PubMed ID: 16880323
[TBL] [Abstract][Full Text] [Related]
20. Association of Serum Uromodulin with Death, Cardiovascular Events, and Kidney Failure in CKD.
Steubl D; Schneider MP; Meiselbach H; Nadal J; Schmid MC; Saritas T; Krane V; Sommerer C; Baid-Agrawal S; Voelkl J; Kotsis F; Köttgen A; Eckardt KU; Scherberich JE;
Clin J Am Soc Nephrol; 2020 May; 15(5):616-624. PubMed ID: 32291270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
